摘要
慢性阻塞性肺疾病,简称:慢阻肺,是一种以气道狭窄和呼吸障碍为特征的慢性炎症性肺疾病。肌少症表现为随年龄增长而出现的肌肉质量和功能减退,肌少症不仅是是慢阻肺发生及发展的独立危险因素,也是导致慢阻肺患者疾病快速进展、住院率及死亡率升高以及不良预后发生的严重并发症之一。因此,对于两种疾病的深入了解,有助于制定有效的管理策略。
Chronic Obstructive Pulmonary Disease, or simply: COPD, is a chronic inflammatory lung disease characterized by narrowed airways and impaired breathing. Sarcopenia manifests as a loss of muscle mass and function with age. Sarcopenia is not only an independent risk factor for the development and progression of chronic obstructive pulmonary disease, but also one of the serious complications leading to rapid disease progression, increased hospitalization and mortality rates, and the occurrence of poor prognosis in patients with chronic obstructive pulmonary disease. Therefore, an in-depth understanding of both diseases can help to develop effective management strategies.
出处
《临床医学进展》
2024年第7期951-957,共7页
Advances in Clinical Medicine